子宫内膜癌前哨淋巴结:原发肿瘤组织学、前哨淋巴结转移大小与非前哨淋巴结转移的关系
414例子宫内膜癌患者按组织学风险分层为低危275例、中危80例、高危59例,接受机器人子宫切除、前哨淋巴结定位、盆腔淋巴结清扫及冰冻切片指导的腹主动脉旁淋巴结清扫。高危组织学患者前哨淋巴结和非前哨淋巴结转移率更高;前哨淋巴结孤立肿瘤细胞在所有风险组均与腹主动脉旁淋巴结转移相关。
要点
- 高危组织学患者前哨淋巴结微/宏转移及非前哨淋巴结转移均较低危/中危患者多。
- 前哨淋巴结孤立肿瘤细胞在所有组织学风险组均与腹主动脉旁淋巴结转移相关。
- 前哨淋巴结定位在高危队列中假阴性率升高但临床可接受。
核心结论
- 高危组织学患者前哨淋巴结微/宏转移及非前哨淋巴结转移均较低危/中危患者多。
- 前哨淋巴结孤立肿瘤细胞在所有组织学风险组均与临床显著的腹主动脉旁淋巴结转移发生率相关。
- 本研究中无孤立腹主动脉旁淋巴结转移病例。
- 前哨淋巴结定位在高危队列中假阴性率较低危患者升高,但临床可接受。
研究设计与样本
- 疑似子宫局限性子宫内膜癌患者接受机器人子宫切除、前哨淋巴结定位、盆腔淋巴结清扫及冰冻切片指导的腹主动脉旁淋巴结清扫。
- 共414例患者按组织学风险分层:低危275例(子宫内膜样癌浸润深度<50%)、中危80例(子宫内膜样癌浸润深度≥50%)、高危59例(II型组织学)。
主要发现
- 盆腔淋巴结转移检出率:低危11.6%、中危50.0%、高危39.0%。
- 腹主动脉旁淋巴结转移检出率:低危2.9%、中危11.3%、高危16.9%。
- 前哨淋巴结孤立肿瘤细胞比例:低危51.6%、中危44.7% vs 高危15.0%(p < 0.05)。
- 前哨淋巴结假阴性率:低危0%、中危2.5%、高危5.1%。
- 全部前哨淋巴结阳性病例中非前哨盆腔淋巴结转移28例(31.5%),前哨淋巴结孤立肿瘤细胞病例中仅3例(8.3%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine sentinel lymph node pathology and describe relationships to uterine pathology, non-sentinel pelvic lymph nodes, and para-aortic lymph nodes. METHODS: Patients with apparent uterine-confined endometrial cancer underwent robotic hysterectomy, SLN mapping, completion pelvic lymphadenectomy (LND), and para-aortic (PaLND) directed by frozen section. Patients were risk stratified by histology: low-risk (LR) endometrioid <50% depth-of-invasion (DOI), intermediate-risk (IR) endometrioid ≥50% DOI, and high-risk (HR) type II histology for comparison to other pelvic/aortic metastases. RESULTS: 414 patients were stratified: 275 LR, 80 IR, and 59 HR cases. PaLND was performed in 84.2% of IR/HR patients and 25.1% LR patients. Pelvic node metastasis was detected in 11.6% LR, 50.0% IR, and 39.0% HR patients. PaLN metastasis was detected in 2.9% LR, 11.3% IR, and 16.9% HR patients. Proportionally, isolated tumor cells (ITC) SLNs were more common in LR or IR vs. HR group (51.6% and 44.7% vs. 15.0%, p < 0.05). The SLN false negative rates (FNR) were 0% LR, 2.5% IR, and 5.1% HR. Non-sentinel pelvic node metastases were present in 28(31.5%) of all SLN+ cases, but only 3(8.3%) of SLN with ITC. PaLN metastasis was found in 18.8% LR, 11.8% IR, and 33.3% HR cases with ITC SLNs. After controlling for DOI, LVSI, and grade, ITC-positive SLNs had a significant association with non-sentinel pelvic and aortic metastasis (p = 0.03 and p = 0.008, respectively). CONCLUSIONS: Patients with HR histology have more micro/macro-metastases in both SLNs and non-SLN metastases compared to LR/IR patients. SLN ITCs were associated with a clinically significant incidence of PaLN metastasis across all histology risk groups. There were no cases of isolated aortic node metastasis in this study. SLN mapping had an increased, although clinically acceptable FNR in the HR cohort compared to LR patients.
引用
- Kennard JA, Stephens AJ, Ahmad S, et al. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis. Gynecol Oncol. 2019. PMID: 31027899. doi:10.1016/j.ygyno.2019.04.654
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。